Back
Mereo BioPharma Group PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison
Sell
45
MREO
Mereo BioPharma Group PLC
Last Price:
3.69
Seasonality Move:
12.89%
Sell
20
ADAP
Adaptimmune Therapeutics PLC
Last Price:
0.66
Seasonality Move:
50.57%
Sell
45
Mereo BioPharma Group PLC (MREO)
is a Sell
Is Mereo BioPharma Group PLC a Buy, Sell or Hold?
- The current Mereo BioPharma Group PLC [MREO] share price is $3.68. The Score for MREO is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- MREO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
20
Adaptimmune Therapeutics PLC (ADAP)
is a Sell
Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?
- The current Adaptimmune Therapeutics PLC [ADAP] share price is $0.64. The Score for ADAP is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ADAP is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MREO Stock Price Chart
What is Mereo BioPharma Group PLC's stock price today?
-
The Mereo BioPharma Group PLC share price today is $3.68
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MREO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ADAP Stock Price Chart
What is Adaptimmune Therapeutics PLC's stock price today?
-
The Adaptimmune Therapeutics PLC share price today is $0.64
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ADAP is experiencing selling pressure, which indicates risk of future bearish movement.
MREO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.19 | Sell |
| Relative Strength Index (14 RSI): | 39.84 | Sell |
| Chaikin Money Flow: | 678381 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.76 - 4.4) | Sell |
| Bollinger Bands (100): | (3.83 - 4.47) | Sell |
ADAP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.06 | Sell |
| Relative Strength Index (14 RSI): | 36.24 | Sell |
| Chaikin Money Flow: | -608296 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.66 - 0.82) | Sell |
| Bollinger Bands (100): | (0.81 - 1.21) | Sell |
MREO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.7 | Sell |
| 20-day SMA: | 3.99 | Sell |
| 50-day SMA: | 4.16 | Sell |
| 200-day SMA: | 3.74 | Sell |
| 8-day EMA: | 3.7 | Sell |
| 20-day EMA: | 3.92 | Sell |
| 50-day EMA: | 4.08 | Sell |
| 200-day EMA: | 3.66 | Buy |
ADAP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.66 | Sell |
| 20-day SMA: | 0.73 | Sell |
| 50-day SMA: | 0.85 | Sell |
| 200-day SMA: | 1.12 | Sell |
| 8-day EMA: | 0.67 | Sell |
| 20-day EMA: | 0.73 | Sell |
| 50-day EMA: | 0.83 | Sell |
| 200-day EMA: | 1 | Sell |
Mereo BioPharma Group PLC Earnings Growth & MREO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.02 per share, and a decrease next year of $0.00 per share.
Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.33 per share.
Mereo BioPharma Group PLC Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Adaptimmune Therapeutics PLC Technical Analysis
| Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||